BULLFROG AI HOLDINGS

2,6300

07-ноября-24 14:59:56

15 мин. задержка

Акции

+0,1200

+4,78%

Сегодняшний диапазон

2,5000 - 2,7400

ISIN

N/A

Источник

NASDAQ

BullFrog AI’s VP Artificial Intelligence to Present at Google’s Cancer AI Symposium

22 окт 2024 06:30:00 Источник Nasdaq GlobeNewswire
Bullfrog AI Announces Closing of Registered Direct Offering and Concurrent Private Placement for Aggregate Gross Proceeds of $3.13 Million

21 окт 2024 10:45:00 Источник Nasdaq GlobeNewswire
Bullfrog AI Announces Pricing of Registered Direct Offering and Concurrent Private Placement for Aggregate Gross Proceeds of $3.13 Million

18 окт 2024 08:30:54 Источник Nasdaq GlobeNewswire
BullFrog AI Strengthens Scientific Advisory Board with the Addition of GSK Veteran and Industry Pioneer Dr. John Baldoni

15 окт 2024 06:30:00 Источник Nasdaq GlobeNewswire
BullFrog AI Announces Publication of Data Supporting Potential of Liver Disease Treatment Candidate BF-114

09 окт 2024 06:30:00 Источник Nasdaq GlobeNewswire
BullFrog AI to Participate at the H.C. Wainwright 26th Annual Global Investment Conference

26 авг 2024 07:00:00 Источник Nasdaq GlobeNewswire
BullFrog AI and Lieber Institute for Brain Development Reveal New Insights into Bipolar Disorder Pathways and Potential Drug Targets

25 июл 2024 06:30:00 Источник Nasdaq GlobeNewswire
Join BullFrog AI’s Exclusive Live Investor Webinar and Q&A Session on June 12

29 май 2024 07:00:00 Источник Nasdaq GlobeNewswire
BullFrog AI and Lieber Institute for Brain Development Collaboration Identifies Novel Drug Targets for Neuropsychiatric Disorders

16 май 2024 07:00:00 Источник Nasdaq GlobeNewswire
BullFrog AI’s CSO, Tom Chittenden, to Present at the Quantum Computing Symposium at Bio-IT World Conference & Expo

09 апр 2024 07:00:00 Источник Nasdaq GlobeNewswire
BullFrog AI Announces Availability of Fireside Chat Recording Featuring CEOs of BullFrog AI and the Lieber Institute

08 мар 2024 07:00:00 Источник Nasdaq GlobeNewswire
BullFrog AI Appoints Globally Renowned Biomedical AI Expert Dr. Thomas W. Chittenden as Chief Scientific Officer

26 фев 2024 07:00:00 Источник Nasdaq GlobeNewswire
BullFrog AI Announces Underwriter’s Decision to Exercise Over-Allotment Option to Purchase 218,382 Shares of the Company’s Common Stock

21 фев 2024 11:01:05 Источник Nasdaq GlobeNewswire
BullFrog AI to Discuss Findings from its Collaboration with Lieber Institute for Brain Development in Fireside Chat Hosted by RedChip

09 фев 2024 07:00:00 Источник Nasdaq GlobeNewswire
BullFrog AI Announces Closing of $5.7 Million Public Offering

05 фев 2024 09:00:57 Источник Nasdaq GlobeNewswire
Bullfrog AI Announces Pricing of $5.7 Million Public Offering

01 фев 2024 08:00:00 Источник Nasdaq GlobeNewswire
BullFrog AI Strengthens Scientific Advisory Board with the Addition of Dr. Gwenn Smith and Dr. Jeremiah Wala

26 янв 2024 06:30:00 Источник Nasdaq GlobeNewswire
BullFrog AI’s Collaboration with Lieber Institute for Brain Development Yields Potentially Groundbreaking Biological Stratification of Brain Expression Data

17 янв 2024 06:00:00 Источник Nasdaq GlobeNewswire
BullFrog AI Announces Issuance of Australian Patent Protecting Novel Prodrugs of Mebendazole and Their Use in Treating Cancer

16 янв 2024 07:00:00 Источник Nasdaq GlobeNewswire
BullFrog AI to Present at Webull LIVE! Healthcare Webinar on January 17

11 янв 2024 15:05:00 Источник Nasdaq GlobeNewswire

<<
<
1
>

Принимаю NetDania's website uses cookies. By continuing browsing our website, you agree to our Правила в отношении Cookies, Политика конфиденциальности and Правила и условия.